Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [11C]AZ14193391
A Swedish clinical trial reveals that positron emission tomography with the PARP1-selective radiopharmaceutical AZ14193391 is feasible, safe, and delivers a ...
![Research report: Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [11C]AZ14193391](https://bioengineer.org/wp-content/uploads/2026/11/stackrss-featured-4179-350x250.png)












![Preclinical Evaluation Assesses [11C]Onalespib for Cancer and Brain PET Imaging](https://bioengineer.org/wp-content/uploads/2026/11/stackrss-featured-2645-350x250.jpg)





![SPECT/CT tracer [123I]I-PARPi mirrors PARP immunohistochemistry across cancers](https://bioengineer.org/wp-content/uploads/2026/11/stackrss-featured-1232-350x250.jpg)
